Perfusion Imaging
Myocardial Perfusion Imaging
Tomography, Emission-Computed, Single-Photon
Chemotherapy, Cancer, Regional Perfusion
Technetium Tc 99m Sestamibi
Organotechnetium Compounds
Ventilation-Perfusion Ratio
Magnetic Resonance Angiography
Laser-Doppler Flowmetry
Radiopharmaceuticals
Blood Flow Velocity
Thallium Radioisotopes
Dipyridamole
Magnetic Resonance Imaging
Oximes
Nitrogen Radioisotopes
Hemodynamics
Myocardial Ischemia
Sensitivity and Specificity
Tomography, X-Ray Computed
Image Processing, Computer-Assisted
Dogs
Adenosine
Technetium Tc 99m Exametazime
Image Enhancement
Ischemia
Gated Blood-Pool Imaging
Brain
Organ Preservation
Reproducibility of Results
Exercise Test
Gadolinium DTPA
Myocardium
Tomography, Emission-Computed
Technetium Tc 99m Aggregated Albumin
Coronary Angiography
Microspheres
Rats, Sprague-Dawley
Oxygen
Image Interpretation, Computer-Assisted
Coronary Disease
Spin Labels
Pressure
Collateral Circulation
Swine
Extracorporeal Circulation
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography
Myocardial Reperfusion
Hindlimb
Rubidium Radioisotopes
Vascular Resistance
Rats, Wistar
Oxygen Consumption
Predictive Value of Tests
Coronary Artery Disease
Organophosphorus Compounds
Liver
Artifacts
Technetium
Feasibility Studies
Positron-Emission Tomography
Ventricular Function, Left
Myocardial Infarction
Xenon Radioisotopes
Intracranial Pressure
Disease Models, Animal
Hyperemia
Oxygen Radioisotopes
Brain Ischemia
Prospective Studies
Rats, Inbred Strains
Hypothermia, Induced
Ventriculography, First-Pass
Krypton
Rabbits
Radioisotopes
Lung
Microvessels
Kidney
Organ Preservation Solutions
Dobutamine
Fluorocarbons
Splanchnic Circulation
Jejunum
Electrocardiography
Vasodilation
Cardiopulmonary Bypass
Treatment Outcome
Radionuclide Imaging
Echocardiography
Carbon Dioxide
Vasoconstriction
Magnetic Resonance Imaging, Cine
Models, Cardiovascular
Heart Arrest, Induced
Diffusion Magnetic Resonance Imaging
Myocardial Stunning
Microdialysis
Fractional Flow Reserve, Myocardial
Algorithms
Capillary Permeability
Acetazolamide
Hyperthermia, Induced
Nitric Oxide
Microbubbles
Echo-Planar Imaging
Models, Animal
Observer Variation
Krypton Radioisotopes
Ammonia
Cerebral Infarction
Melphalan
Pulmonary Gas Exchange
Ventricular Dysfunction, Left
Dose-Response Relationship, Drug
Iohexol
Radionuclide Angiography
Imaging, Three-Dimensional
Partial Pressure
Neovascularization, Physiologic
Warm Ischemia
Stroke
Arterioles
Norepinephrine
Glucose
Mannitol
Middle Cerebral Artery
Albumins
Sulfur Hexafluoride
Isotonic Solutions
Indocyanine Green
Xenon
Organometallic Compounds
Endothelium, Vascular
Cerebral Angiography
Cardiac Output
Severity of Illness Index
Subtraction Technique
Stroke Volume
Pulsatile Flow
Aqueous Humor
Bioreactors
Follow-Up Studies
Noble Gases
Reference Values
Lactic Acid
Hepatic Artery
Retrospective Studies
Arterial Occlusive Diseases
Phantoms, Imaging
ROC Curve
Angina Pectoris
Iofetamine
Heart Ventricles
Blood Volume Determination
Prognosis
Circulatory Arrest, Deep Hypothermia Induced
Calcium
Analysis of Variance
Raffinose
Tomography, Spiral Computed
Sturge-Weber Syndrome
Echocardiography, Stress
Tissue Preservation
Infarction, Middle Cerebral Artery
The effect of cardiac contraction on collateral resistance in the canine heart. (1/6670)
We determined whether the coronary collateral vessels develop an increased resistance to blood flow during systole as does the cognate vascular bed. Collateral resistance was estimated by measuring retrograde flow rate from a distal branch of the left anterior descending coronary artery while the main left coronary artery was perfused at a constant pressure. Retrograde flow rate was measured before and during vagal arrest. We found that in 10 dogs the prolonged diastole experienced when the heart was stopped caused no significant change in the retrograde flow rate, which indicated that systole has little effect on the collateral resistance. However, when left ventricular end-diastolic pressure was altered by changing afterload or contractility, a direct relationship between end-diastolic pressure and collateral resistance was noted. (+info)Effect of tumor necrosis factor alpha on vascular resistance, nitric oxide production, and glucose and oxygen consumption in perfused tissue-isolated human melanoma xenografts. (2/6670)
The effect of tumor necrosis factor alpha (TNF-alpha) on vascular resistance, nitric oxide production, and consumption of oxygen and glucose was examined in a perfused tissue-isolated tumor model in nude mice. One experimental group was perfused with heparinized Krebs-Henseleit buffer, a second one was perfused with TNF-alpha (500 microgram/kg) 5 h before perfusion. The vascular resistance increased significantly 5 h after TNF-alpha injection. The increase in vascular resistance did not seem to be mediated by a decrease in tumor nitric oxide production, as determined by perfusate nitrate/nitrite concentrations, but may be due to aggregation of leukocytes, platelets, and erythrocytes and/or endothelial consumption among the three experimental groups. The oxygen consumption was linearly dependent on the amount of available oxygen in the perfusate, whereas the glucose consumption was constant and independent of the glucose delivery rate. The present experiments provide new insights into physiological and metabolic mechanisms of action of TNF- alpha for optimization of future treatment schedules involving TNF-alpha. (+info)Drug-protein binding and blood-brain barrier permeability. (3/6670)
The permeability surface area (PS) product, an index of permeability of the blood-brain barrier (BBB), was measured by using the in situ perfusion method. In the cerebral circulation, the fraction of drug that permeates into the brain through the BBB is not only the unbound fraction but also the fraction dissociated from the protein in the perfusate. The sum of these two fractions, the apparent exchangeable fraction, was estimated by fitting the parameters of the BBB permeability under the condition of varying BSA concentrations in the perfusate. The unbound fraction of drugs in a buffer containing 0.5 mM BSA was measured by using the ultrafiltration method in vitro, and the apparent exchangeable fraction was measured in vivo by using the intracarotid artery injection method. The apparent exchange fraction was 100% for S-8510, 96.5% for diazepam, 90.9% for caffeine, 38.3% for S-312-d, 33.1% for propranolol, and 6.68% for (+)-S-145 Na, and each of these was higher than the corresponding unbound fraction in vitro in all drugs. The apparent exchangeable fractions, for example, were 8 times higher for diazepam and 38 times for S-312-d than the unbound fractions in vitro. The apparent exchangeable fraction of drugs was also estimated from the parameters obtained with the perfusion method. Because drugs can be infused for an arbitrary length of time in the perfusion method, substances with low permeability can be measured. The apparent exchangeable fractions obtained with this method were almost the same as those obtained with the intracarotid artery injection method. (+info)Effects of inhibitors and substitutes for chloride in lumen on p-aminohippurate transport by isolated perfused rabbit renal proximal tubules. (4/6670)
The transport step for p-aminohippurate (PAH) from cell to lumen across the luminal membrane of rabbit proximal tubules has not been adequately defined. To examine this process more closely, we determined the effects of possible transport inhibitors and substitutes for chloride on PAH secretion in isolated perfused S2 segments of rabbit proximal tubules. The addition of 4-acetamido-4'-isothiocyano-2,2' disulfonic stilbene (10(-4) M) to the perfusate irreversibly inhibited PAH secretion, whereas the addition of probenecid (10(-4) M) to the perfusate reversibly inhibited PAH secretion. PAH secretion was unaffected by thiocyanate replacement of chloride in the luminal perfusate, reversibly inhibited by 15 to 20% by methyl sulfate replacement, and irreversibly inhibited by isethionate replacement. Because the luminal membrane is at least as permeable to thiocyanate as to chloride, less permeable to methyl sulfate, and much less permeable to isethionate, these data suggest that the PAH transport step from cells to lumen does not require chloride in the lumen but does require a highly permeant anion. During inhibition of PAH transport from cells to lumen, PAH uptake across the basolateral membrane was also reduced, suggesting some type of feedback inhibition. The data are compatible with PAH transport across the luminal membrane by an anion exchanger, a potential-driven uniporter, both carriers, or a carrier that can function in both modes. (+info)The mechanism of the increasing action of TA-993, a new 1,5- benzothiazepine derivative, on limb blood flow in anesthetized dogs: selective suppression of sympathetic nerve activity. (5/6670)
TA-993, (-)-cis-3-acetoxy-5-(2-(dimethylamino)ethyl)-2, 3-di-hydro-8-methyl-2-(4-methylphenyl)-1,5-benzothiazepin-4(5H)one maleate, a new 1,5-benzothiazepine derivative with l-cis configuration, has a unique and selective increasing action on limb blood flow with little influence on arterial pressure besides an antiplatelet action. We studied the mechanism of increasing action of TA-993 on limb blood flow in anesthetized dogs. In a canine blood-perfused hindlimb preparation with a donor dog, TA-993 (100 microg/kg i.v.) did not increase femoral blood flow when administered to the donor dog, but did when administered to a recipient dog. TA-993 did not show the increasing action on femoral blood flow in the presence of hexamethonium or phentolamine, whereas it did in the presence of propranolol or atropine. TA-993 also showed a weak increasing effect on heart rate, which was inhibited by any one of these blockers. TA-993 (300 microg/kg i.v.) did not alter the phenylephrine (1-100 ng/kg i.a.)- or the talipexole (3-100 ng/kg i.a.)-induced increase in perfusion pressure in an autoperfused hindlimb. These results suggest that the increasing action of TA-993 on limb blood flow is mediated by the sympathetic nervous system but that the adrenergic receptors are not likely to be the central point of action of this new agent. There is a possibility that the mechanism of the increasing action on heart rate is different from that of its increasing action on limb blood flow. (+info)Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH. (6/6670)
BACKGROUND: The kallikrein-kinin system activation by contact with a negatively charged surface has been promulgated to be responsible for hypersensitivity reactions. However, to explain the low frequency and heterogeneity of hypersensitivity reactions, we hypothesized that not only the electronegativity of the membrane, but also other physicochemical parameters could influence the activation of the contact phase system of plasma assessed by the measurement of kallikrein activity and bradykinin concentration. METHODS: Plasma kallikrein activity using chromogenic substrate (S2302) and plasma bradykinin concentration (enzyme immuno assay) were measured during the perfusion of human plasma (2.5 ml/min) through minidialyzers mounted with six different membranes [polyacrylonitrile (PAN) from Asahi (PANDX) and from Hospal (AN69), polymethylmethacrylate (PMMA) from Toray, cellulose triacetate (CT) from Baxter, cuprophane (CUP) from Akzo and polysulfone (PS) from Fresenius]. RESULTS: A direct relationship was shown between the electronegativity of the membrane assessed by its zeta potential and the activation of plasma during the first five minutes of plasma circulation. With the AN69 membrane, the detection of a kallikrein activity in diluted plasma but not in undiluted samples confirmed the importance of a protease-antiprotease imbalance leading to bradykinin release during the first five minutes of dialysis. With PAN membranes, the use of citrated versus heparinized plasma and the use of various rinsing solutions clearly show a dramatic effect of pH on the kallikrein activity and the bradykinin concentration measured in plasma. Finally, increasing the zeta potential of the membrane leads to a significant increase of plasma kallikrein activity and bradykinin concentration. CONCLUSIONS: Our in vitro experimental approach evidences the importance of the control of these physicochemical factors to decrease the activation of the contact system. (+info)Three-independent-compartment chamber to study in vitro commissural synapses. (7/6670)
We describe a novel chamber in which the two intact neonatal rat hippocampi and the commissural fibers are placed in three independent compartments separated by latex membranes and perfused selectively with different solutions. A set of control tests showed that the compartments are well isolated: 1) methylene blue or eosin applied to one compartment did not diffuse to other compartments when verified via the microscope, and spectrophotometry revealed that <1/10.000th of the dye diffuses to other compartments; 2) tetrodotoxin (1 microM) applied to the commissural compartment blocked the synaptic responses evoked contralaterally without affecting those evoked on the ipsilateral side. This chamber enables a wide range of experiments that cannot be performed in conventional chambers, e.g., to study the maturation and plasticity of the commissural connections, bilateral synchronization of the rhythmic activities in the limbic system, commissural propagation of the epileptiform activities, etc. (+info)Influence of renal failure on intestinal clearance of ciprofloxacin in rats. (8/6670)
Following intravenous doses, ciprofloxacin pharmacokinetics in control and nephrectomized rats were studied. There were no differences between control and nephrectomized rats for area under the concentration-time curve in plasma or biliary clearance. The intestinal clearance of ciprofloxacin was increased in nephrectomized rats. Intestinal elimination seems to compensate partially for the decrease in urinary excretion of ciprofloxacin in nephrectomized rats. (+info)Myocardial ischemia can be caused by a variety of factors, including coronary artery disease, high blood pressure, diabetes, and smoking. It can also be triggered by physical exertion or stress.
There are several types of myocardial ischemia, including:
1. Stable angina: This is the most common type of myocardial ischemia, and it is characterized by a predictable pattern of chest pain that occurs during physical activity or emotional stress.
2. Unstable angina: This is a more severe type of myocardial ischemia that can occur without any identifiable trigger, and can be accompanied by other symptoms such as shortness of breath or vomiting.
3. Acute coronary syndrome (ACS): This is a condition that includes both stable angina and unstable angina, and it is characterized by a sudden reduction in blood flow to the heart muscle.
4. Heart attack (myocardial infarction): This is a type of myocardial ischemia that occurs when the blood flow to the heart muscle is completely blocked, resulting in damage or death of the cardiac tissue.
Myocardial ischemia can be diagnosed through a variety of tests, including electrocardiograms (ECGs), stress tests, and imaging studies such as echocardiography or cardiac magnetic resonance imaging (MRI). Treatment options for myocardial ischemia include medications such as nitrates, beta blockers, and calcium channel blockers, as well as lifestyle changes such as quitting smoking, losing weight, and exercising regularly. In severe cases, surgical procedures such as coronary artery bypass grafting or angioplasty may be necessary.
There are several types of ischemia, including:
1. Myocardial ischemia: Reduced blood flow to the heart muscle, which can lead to chest pain or a heart attack.
2. Cerebral ischemia: Reduced blood flow to the brain, which can lead to stroke or cognitive impairment.
3. Peripheral arterial ischemia: Reduced blood flow to the legs and arms.
4. Renal ischemia: Reduced blood flow to the kidneys.
5. Hepatic ischemia: Reduced blood flow to the liver.
Ischemia can be diagnosed through a variety of tests, including electrocardiograms (ECGs), stress tests, and imaging studies such as CT or MRI scans. Treatment for ischemia depends on the underlying cause and may include medications, lifestyle changes, or surgical interventions.
Coronary disease is often caused by a combination of genetic and lifestyle factors, such as high blood pressure, high cholesterol levels, smoking, obesity, and a lack of physical activity. It can also be triggered by other medical conditions, such as diabetes and kidney disease.
The symptoms of coronary disease can vary depending on the severity of the condition, but may include:
* Chest pain or discomfort (angina)
* Shortness of breath
* Fatigue
* Swelling of the legs and feet
* Pain in the arms and back
Coronary disease is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as electrocardiograms (ECGs), stress tests, and cardiac imaging. Treatment for coronary disease may include lifestyle changes, medications to control symptoms, and surgical procedures such as angioplasty or bypass surgery to improve blood flow to the heart.
Preventative measures for coronary disease include:
* Maintaining a healthy diet and exercise routine
* Quitting smoking and limiting alcohol consumption
* Managing high blood pressure, high cholesterol levels, and other underlying medical conditions
* Reducing stress through relaxation techniques or therapy.
The buildup of plaque in the coronary arteries is often caused by high levels of low-density lipoprotein (LDL) cholesterol, smoking, high blood pressure, diabetes, and a family history of heart disease. The plaque can also rupture, causing a blood clot to form, which can completely block the flow of blood to the heart muscle, leading to a heart attack.
CAD is the most common type of heart disease and is often asymptomatic until a serious event occurs. Risk factors for CAD include:
* Age (men over 45 and women over 55)
* Gender (men are at greater risk than women, but women are more likely to die from CAD)
* Family history of heart disease
* High blood pressure
* High cholesterol
* Diabetes
* Smoking
* Obesity
* Lack of exercise
Diagnosis of CAD typically involves a physical exam, medical history, and results of diagnostic tests such as:
* Electrocardiogram (ECG or EKG)
* Stress test
* Echocardiogram
* Coronary angiography
Treatment for CAD may include lifestyle changes such as a healthy diet, regular exercise, stress management, and quitting smoking. Medications such as beta blockers, ACE inhibitors, and statins may also be prescribed to manage symptoms and slow the progression of the disease. In severe cases, surgical intervention such as coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) may be necessary.
Prevention of CAD includes managing risk factors such as high blood pressure, high cholesterol, and diabetes, quitting smoking, maintaining a healthy weight, and getting regular exercise. Early detection and treatment of CAD can help to reduce the risk of complications and improve quality of life for those affected by the disease.
There are different types of myocardial infarctions, including:
1. ST-segment elevation myocardial infarction (STEMI): This is the most severe type of heart attack, where a large area of the heart muscle is damaged. It is characterized by a specific pattern on an electrocardiogram (ECG) called the ST segment.
2. Non-ST-segment elevation myocardial infarction (NSTEMI): This type of heart attack is less severe than STEMI, and the damage to the heart muscle may not be as extensive. It is characterized by a smaller area of damage or a different pattern on an ECG.
3. Incomplete myocardial infarction: This type of heart attack is when there is some damage to the heart muscle but not a complete blockage of blood flow.
4. Collateral circulation myocardial infarction: This type of heart attack occurs when there are existing collateral vessels that bypass the blocked coronary artery, which reduces the amount of damage to the heart muscle.
Symptoms of a myocardial infarction can include chest pain or discomfort, shortness of breath, lightheadedness, and fatigue. These symptoms may be accompanied by anxiety, fear, and a sense of impending doom. In some cases, there may be no noticeable symptoms at all.
Diagnosis of myocardial infarction is typically made based on a combination of physical examination findings, medical history, and diagnostic tests such as an electrocardiogram (ECG), cardiac enzyme tests, and imaging studies like echocardiography or cardiac magnetic resonance imaging.
Treatment of myocardial infarction usually involves medications to relieve pain, reduce the amount of work the heart has to do, and prevent further damage to the heart muscle. These may include aspirin, beta blockers, ACE inhibitors or angiotensin receptor blockers, and statins. In some cases, a procedure such as angioplasty or coronary artery bypass surgery may be necessary to restore blood flow to the affected area.
Prevention of myocardial infarction involves managing risk factors such as high blood pressure, high cholesterol, smoking, diabetes, and obesity. This can include lifestyle changes such as a healthy diet, regular exercise, and stress reduction, as well as medications to control these conditions. Early detection and treatment of heart disease can help prevent myocardial infarction from occurring in the first place.
1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.
2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.
3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.
4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.
5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.
6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.
7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.
8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.
9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.
10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.
In some cases, hyperemia can be a sign of a more serious underlying condition that requires medical attention. For example, if hyperemia is caused by an inflammatory or infectious process, it may lead to tissue damage or organ dysfunction if left untreated.
Hyperemia can occur in various parts of the body, including the skin, muscles, organs, and other tissues. It is often diagnosed through physical examination and imaging tests such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI). Treatment for hyperemia depends on its underlying cause, and may include antibiotics, anti-inflammatory medications, or surgery.
In the context of dermatology, hyperemia is often used to describe a condition called erythema, which is characterized by redness and swelling of the skin due to increased blood flow. Erythema can be caused by various factors, such as sun exposure, allergic reactions, or skin infections. Treatment for erythema may include topical medications, oral medications, or other therapies depending on its underlying cause.
The term ischemia refers to the reduction of blood flow, and it is often used interchangeably with the term stroke. However, not all strokes are caused by ischemia, as some can be caused by other factors such as bleeding in the brain. Ischemic stroke accounts for about 87% of all strokes.
There are different types of brain ischemia, including:
1. Cerebral ischemia: This refers to the reduction of blood flow to the cerebrum, which is the largest part of the brain and responsible for higher cognitive functions such as thought, emotion, and voluntary movement.
2. Cerebellar ischemia: This refers to the reduction of blood flow to the cerebellum, which is responsible for coordinating and regulating movement, balance, and posture.
3. Brainstem ischemia: This refers to the reduction of blood flow to the brainstem, which is responsible for controlling many of the body's automatic functions such as breathing, heart rate, and blood pressure.
4. Territorial ischemia: This refers to the reduction of blood flow to a specific area of the brain, often caused by a blockage in a blood vessel.
5. Global ischemia: This refers to the reduction of blood flow to the entire brain, which can be caused by a cardiac arrest or other systemic conditions.
The symptoms of brain ischemia can vary depending on the location and severity of the condition, but may include:
1. Weakness or paralysis of the face, arm, or leg on one side of the body
2. Difficulty speaking or understanding speech
3. Sudden vision loss or double vision
4. Dizziness or loss of balance
5. Confusion or difficulty with memory
6. Seizures
7. Slurred speech or inability to speak
8. Numbness or tingling sensations in the face, arm, or leg
9. Vision changes, such as blurred vision or loss of peripheral vision
10. Difficulty with coordination and balance.
It is important to seek medical attention immediately if you experience any of these symptoms, as brain ischemia can cause permanent damage or death if left untreated.
The severity of coronary stenosis can range from mild to severe, with blockages ranging from 15% to over 90%. In mild cases, lifestyle changes and medication may be enough to manage symptoms. However, more severe cases typically require interventional procedures such as angioplasty or bypass surgery to improve blood flow to the heart.
The symptoms of pulmonary embolism can vary, but may include shortness of breath, chest pain, coughing up blood, rapid heart rate, and fever. In some cases, the clot may be large enough to cause a pulmonary infarction (a " lung injury" caused by lack of oxygen), which can lead to respiratory failure and death.
Pulmonary embolism can be diagnosed with imaging tests such as chest X-rays, CT scans, and ultrasound. Treatment typically involves medications to dissolve the clot or prevent new ones from forming, and in some cases, surgery may be necessary to remove the clot.
Preventive measures include:
* Avoiding prolonged periods of immobility, such as during long-distance travel
* Exercising regularly to improve circulation
* Managing chronic conditions such as high blood pressure and cancer
* Taking blood-thinning medications to prevent clot formation
Early recognition and treatment of pulmonary embolism are critical to reduce the risk of complications and death.
During myocardial stunning, the heart muscle cells experience a temporary reduction in contractility and an increase in the amount of lactic acid produced. This can lead to symptoms such as chest pain, shortness of breath, and fatigue. In severe cases, myocardial stunning can progress to myocardial infarction (heart attack) or cardiac arrest.
Myocardial stunning is often seen in athletes who engage in intense exercise, such as marathon runners or professional football players. It can also occur in people with pre-existing heart conditions, such as coronary artery disease or hypertension.
Treatment of myocardial stunning typically involves addressing the underlying cause, such as reducing stress on the heart or improving blood flow to the myocardium. In severe cases, medications such as nitrates or beta blockers may be used to reduce the workload on the heart and improve contractility. In some cases, hospitalization may be necessary to monitor the condition and provide appropriate treatment.
Prevention of myocardial stunning involves taking steps to reduce the risk factors for heart disease, such as maintaining a healthy diet, exercising regularly, and managing stress. It is also important to seek medical attention if symptoms of myocardial stunning are present, as prompt treatment can help prevent more severe complications.
Examples of acute diseases include:
1. Common cold and flu
2. Pneumonia and bronchitis
3. Appendicitis and other abdominal emergencies
4. Heart attacks and strokes
5. Asthma attacks and allergic reactions
6. Skin infections and cellulitis
7. Urinary tract infections
8. Sinusitis and meningitis
9. Gastroenteritis and food poisoning
10. Sprains, strains, and fractures.
Acute diseases can be treated effectively with antibiotics, medications, or other therapies. However, if left untreated, they can lead to chronic conditions or complications that may require long-term care. Therefore, it is important to seek medical attention promptly if symptoms persist or worsen over time.
Cerebral infarction can result in a range of symptoms, including sudden weakness or numbness in the face, arm, or leg on one side of the body, difficulty speaking or understanding speech, sudden vision loss, dizziness, and confusion. Depending on the location and severity of the infarction, it can lead to long-term disability or even death.
There are several types of cerebral infarction, including:
1. Ischemic stroke: This is the most common type of cerebral infarction, accounting for around 87% of all cases. It occurs when a blood clot blocks the flow of blood to the brain, leading to cell death and tissue damage.
2. Hemorrhagic stroke: This type of cerebral infarction occurs when a blood vessel in the brain ruptures, leading to bleeding and cell death.
3. Lacunar infarction: This type of cerebral infarction affects the deep structures of the brain, particularly the basal ganglia, and is often caused by small blockages or stenosis (narrowing) in the blood vessels.
4. Territorial infarction: This type of cerebral infarction occurs when there is a complete blockage of a blood vessel that supplies a specific area of the brain, leading to cell death and tissue damage in that area.
Diagnosis of cerebral infarction typically involves a combination of physical examination, medical history, and imaging tests such as CT or MRI scans. Treatment options vary depending on the cause and location of the infarction, but may include medication to dissolve blood clots, surgery to remove blockages, or supportive care to manage symptoms and prevent complications.
There are several potential causes of LVD, including:
1. Coronary artery disease: The buildup of plaque in the coronary arteries can lead to a heart attack, which can damage the left ventricle and impair its ability to function properly.
2. Heart failure: When the heart is unable to pump enough blood to meet the body's needs, it can lead to LVD.
3. Cardiomyopathy: This is a condition where the heart muscle becomes weakened or enlarged, leading to impaired function of the left ventricle.
4. Heart valve disease: Problems with the heart valves can disrupt the normal flow of blood and cause LVD.
5. Hypertension: High blood pressure can cause damage to the heart muscle and lead to LVD.
6. Genetic factors: Some people may be born with genetic mutations that predispose them to developing LVD.
7. Viral infections: Certain viral infections, such as myocarditis, can inflame and damage the heart muscle, leading to LVD.
8. Alcohol or drug abuse: Substance abuse can damage the heart muscle and lead to LVD.
9. Nutritional deficiencies: A diet lacking essential nutrients can lead to damage to the heart muscle and increase the risk of LVD.
Diagnosis of LVD typically involves a physical exam, medical history, and results of diagnostic tests such as electrocardiograms (ECGs), echocardiograms, and stress tests. Treatment options for LVD depend on the underlying cause, but may include medications to improve cardiac function, lifestyle changes, and in severe cases, surgery or other procedures.
Preventing LVD involves taking steps to maintain a healthy heart and reducing risk factors such as high blood pressure, smoking, and obesity. This can be achieved through a balanced diet, regular exercise, stress management, and avoiding substance abuse. Early detection and treatment of underlying conditions that increase the risk of LVD can also help prevent the condition from developing.
1. Ischemic stroke: This is the most common type of stroke, accounting for about 87% of all strokes. It occurs when a blood vessel in the brain becomes blocked, reducing blood flow to the brain.
2. Hemorrhagic stroke: This type of stroke occurs when a blood vessel in the brain ruptures, causing bleeding in the brain. High blood pressure, aneurysms, and blood vessel malformations can all cause hemorrhagic strokes.
3. Transient ischemic attack (TIA): Also known as a "mini-stroke," a TIA is a temporary interruption of blood flow to the brain that lasts for a short period of time, usually less than 24 hours. TIAs are often a warning sign for a future stroke and should be taken seriously.
Stroke can cause a wide range of symptoms depending on the location and severity of the damage to the brain. Some common symptoms include:
* Weakness or numbness in the face, arm, or leg
* Difficulty speaking or understanding speech
* Sudden vision loss or double vision
* Dizziness, loss of balance, or sudden falls
* Severe headache
* Confusion, disorientation, or difficulty with memory
Stroke is a leading cause of long-term disability and can have a significant impact on the quality of life for survivors. However, with prompt medical treatment and rehabilitation, many people are able to recover some or all of their lost functions and lead active lives.
The medical community has made significant progress in understanding stroke and developing effective treatments. Some of the most important advances include:
* Development of clot-busting drugs and mechanical thrombectomy devices to treat ischemic strokes
* Improved imaging techniques, such as CT and MRI scans, to diagnose stroke and determine its cause
* Advances in surgical techniques for hemorrhagic stroke
* Development of new medications to prevent blood clots and reduce the risk of stroke
Despite these advances, stroke remains a significant public health problem. According to the American Heart Association, stroke is the fifth leading cause of death in the United States and the leading cause of long-term disability. In 2017, there were over 795,000 strokes in the United States alone.
There are several risk factors for stroke that can be controlled or modified. These include:
* High blood pressure
* Diabetes mellitus
* High cholesterol levels
* Smoking
* Obesity
* Lack of physical activity
* Poor diet
In addition to these modifiable risk factors, there are also several non-modifiable risk factors for stroke, such as age (stroke risk increases with age), family history of stroke, and previous stroke or transient ischemic attack (TIA).
The medical community has made significant progress in understanding the causes and risk factors for stroke, as well as developing effective treatments and prevention strategies. However, more research is needed to improve outcomes for stroke survivors and reduce the overall burden of this disease.
There are different types of anoxia, including:
1. Cerebral anoxia: This occurs when the brain does not receive enough oxygen, leading to cognitive impairment, confusion, and loss of consciousness.
2. Pulmonary anoxia: This occurs when the lungs do not receive enough oxygen, leading to shortness of breath, coughing, and chest pain.
3. Cardiac anoxia: This occurs when the heart does not receive enough oxygen, leading to cardiac arrest and potentially death.
4. Global anoxia: This is a complete lack of oxygen to the entire body, leading to widespread tissue damage and death.
Treatment for anoxia depends on the underlying cause and the severity of the condition. In some cases, hospitalization may be necessary to provide oxygen therapy, pain management, and other supportive care. In severe cases, anoxia can lead to long-term disability or death.
Prevention of anoxia is important, and this includes managing underlying medical conditions such as heart disease, diabetes, and respiratory problems. It also involves avoiding activities that can lead to oxygen deprivation, such as scuba diving or high-altitude climbing, without proper training and equipment.
In summary, anoxia is a serious medical condition that occurs when there is a lack of oxygen in the body or specific tissues or organs. It can cause cell death and tissue damage, leading to serious health complications and even death if left untreated. Early diagnosis and treatment are crucial to prevent long-term disability or death.
Types of Arterial Occlusive Diseases:
1. Atherosclerosis: Atherosclerosis is a condition where plaque builds up inside the arteries, leading to narrowing or blockages that can restrict blood flow to certain areas of the body.
2. Peripheral Artery Disease (PAD): PAD is a condition where the blood vessels in the legs and arms become narrowed or blocked, leading to pain or cramping in the affected limbs.
3. Coronary Artery Disease (CAD): CAD is a condition where the coronary arteries, which supply blood to the heart, become narrowed or blocked, leading to chest pain or a heart attack.
4. Carotid Artery Disease: Carotid artery disease is a condition where the carotid arteries, which supply blood to the brain, become narrowed or blocked, leading to stroke or mini-stroke.
5. Renal Artery Stenosis: Renal artery stenosis is a condition where the blood vessels that supply the kidneys become narrowed or blocked, leading to high blood pressure and decreased kidney function.
Symptoms of Arterial Occlusive Diseases:
1. Pain or cramping in the affected limbs
2. Weakness or fatigue
3. Difficulty walking or standing
4. Chest pain or discomfort
5. Shortness of breath
6. Dizziness or lightheadedness
7. Stroke or mini-stroke
Treatment for Arterial Occlusive Diseases:
1. Medications: Medications such as blood thinners, cholesterol-lowering drugs, and blood pressure medications may be prescribed to treat arterial occlusive diseases.
2. Lifestyle Changes: Lifestyle changes such as quitting smoking, exercising regularly, and eating a healthy diet can help manage symptoms and slow the progression of the disease.
3. Endovascular Procedures: Endovascular procedures such as angioplasty and stenting may be performed to open up narrowed or blocked blood vessels.
4. Surgery: In some cases, surgery may be necessary to treat arterial occlusive diseases, such as bypass surgery or carotid endarterectomy.
Prevention of Arterial Occlusive Diseases:
1. Maintain a healthy diet and lifestyle
2. Quit smoking and avoid exposure to secondhand smoke
3. Exercise regularly
4. Manage high blood pressure, high cholesterol, and diabetes
5. Avoid excessive alcohol consumption
6. Get regular check-ups with your healthcare provider
Early detection and treatment of arterial occlusive diseases can help manage symptoms, slow the progression of the disease, and prevent complications such as heart attack or stroke.
Angina pectoris is a medical condition that is characterized by recurring chest pain or discomfort due to reduced blood flow and oxygen supply to the heart muscle, specifically the myocardium. It is also known as stable angina or effort angina. The symptoms of angina pectoris typically occur during physical activity or emotional stress and are relieved by rest.
The term "angina" comes from the Latin word for "strangulation," which refers to the feeling of tightness or constriction in the chest that is associated with the condition. Angina pectoris can be caused by atherosclerosis, or the buildup of plaque in the coronary arteries, which supply blood to the heart muscle. This buildup can lead to the formation of atherosclerotic plaques that can narrow the coronary arteries and reduce blood flow to the heart muscle, causing chest pain.
There are several types of angina pectoris, including:
1. Stable angina: This is the most common type of angina and is characterized by predictable and reproducible symptoms that occur during specific situations or activities, such as exercise or emotional stress.
2. Unstable angina: This type of angina is characterized by unpredictable and changing symptoms that can occur at rest or with minimal exertion. It is often a sign of a more severe underlying condition, such as a heart attack.
3. Variant angina: This type of angina occurs during physical activity, but the symptoms are not relieved by rest.
4. Prinzmetal's angina: This is a rare type of angina that occurs at rest and is characterized by a feeling of tightness or constriction in the chest.
The diagnosis of angina pectoris is typically made based on a combination of physical examination, medical history, and diagnostic tests such as electrocardiogram (ECG), stress test, and imaging studies. Treatment for angina pectoris usually involves lifestyle modifications, such as regular exercise, a healthy diet, and stress management, as well as medications to relieve symptoms and reduce the risk of complications. In some cases, surgery or other procedures may be necessary to treat the underlying condition causing the angina.
Symptoms of Sturge-Weber Syndrome can vary in severity and may include:
* Port-wine stain (nevus flammeus) on one side of the face and/or neck
* Seizures, including epilepsy
* Developmental delays and intellectual disability
* Vision problems, including glaucoma, cataracts, and visual field defects
* Hearing loss
* Scoliosis or other spinal abnormalities
* Weakened muscles (hypotonia)
There is no cure for Sturge-Weber Syndrome, but various treatments can help manage the symptoms. These may include:
* Anticonvulsant medications to control seizures
* Surgery to remove the port-wine stain or repair related eye problems
* Physical therapy to improve muscle strength and coordination
* Speech and language therapy to address communication difficulties
* Occupational therapy to help with daily living skills
The prognosis for Sturge-Weber Syndrome varies depending on the severity of the disorder and the presence of other health problems. Some individuals with the condition may have a relatively mild course, while others may experience more significant challenges. With appropriate medical care and support, many individuals with Sturge-Weber Syndrome can lead fulfilling lives.
Infarction Middle Cerebral Artery (MCA) is a type of ischemic stroke that occurs when there is an obstruction in the middle cerebral artery. This artery supplies blood to the temporal lobe of the brain, which controls many important functions such as memory, language, and spatial reasoning. When this artery becomes blocked or ruptured, it can cause a lack of blood supply to the affected areas resulting in tissue death (infarction).
The symptoms of an MCA infarction can vary depending on the location and severity of the blockage. Some common symptoms include weakness or paralysis on one side of the body, difficulty with speech and language, memory loss, confusion, vision problems, and difficulty with coordination and balance. Patients may also experience sudden severe headache, nausea, vomiting, and fever.
The diagnosis of MCA infarction is based on a combination of clinical examination, imaging studies such as CT or MRI scans, and laboratory tests. Imaging studies can help to identify the location and severity of the blockage, while laboratory tests may be used to rule out other conditions that may cause similar symptoms.
Treatment for MCA infarction depends on the underlying cause of the blockage or rupture. In some cases, medications such as thrombolytics may be given to dissolve blood clots and restore blood flow to the affected areas. Surgery may also be required to remove any blockages or repair damaged blood vessels. Other interventions such as endovascular procedures or brain bypass surgery may also be used to restore blood flow.
In summary, middle cerebral artery infarction is a type of stroke that occurs when the blood supply to the brain is blocked or interrupted, leading to damage to the brain tissue. It can cause a range of symptoms including weakness or paralysis on one side of the body, difficulty with speech and language, memory loss, confusion, vision problems, and difficulty with coordination and balance. The diagnosis is based on a combination of clinical examination, imaging studies, and laboratory tests. Treatment options include medications, surgery, endovascular procedures, or brain bypass surgery.
Reperfusion injury can cause inflammation, cell death, and impaired function in the affected tissue or organ. The severity of reperfusion injury can vary depending on the duration and severity of the initial ischemic event, as well as the promptness and effectiveness of treatment to restore blood flow.
Reperfusion injury can be a complicating factor in various medical conditions, including:
1. Myocardial infarction (heart attack): Reperfusion injury can occur when blood flow is restored to the heart muscle after a heart attack, leading to inflammation and cell death.
2. Stroke: Reperfusion injury can occur when blood flow is restored to the brain after an ischemic stroke, leading to inflammation and damage to brain tissue.
3. Organ transplantation: Reperfusion injury can occur when a transplanted organ is subjected to ischemia during harvesting or preservation, and then reperfused with blood.
4. Peripheral arterial disease: Reperfusion injury can occur when blood flow is restored to a previously occluded peripheral artery, leading to inflammation and damage to the affected tissue.
Treatment of reperfusion injury often involves medications to reduce inflammation and oxidative stress, as well as supportive care to manage symptoms and prevent further complications. In some cases, experimental therapies such as stem cell transplantation or gene therapy may be used to promote tissue repair and regeneration.
MRI can occur in various cardiovascular conditions, such as myocardial infarction (heart attack), cardiac arrest, and cardiac surgery. The severity of MRI can range from mild to severe, depending on the extent and duration of the ischemic event.
The pathophysiology of MRI involves a complex interplay of various cellular and molecular mechanisms. During ischemia, the heart muscle cells undergo changes in energy metabolism, electrolyte balance, and cell membrane function. When blood flow is restored, these changes can lead to an influx of calcium ions into the cells, activation of enzymes, and production of reactive oxygen species (ROS), which can damage the cells and their membranes.
The clinical presentation of MRI can vary depending on the severity of the injury. Some patients may experience chest pain, shortness of breath, and fatigue. Others may have more severe symptoms, such as cardiogenic shock or ventricular arrhythmias. The diagnosis of MRI is based on a combination of clinical findings, electrocardiography (ECG), echocardiography, and cardiac biomarkers.
The treatment of MRI is focused on addressing the underlying cause of the injury and managing its symptoms. For example, in patients with myocardial infarction, thrombolysis or percutaneous coronary intervention may be used to restore blood flow to the affected area. In patients with cardiac arrest, cardiopulmonary resuscitation (CPR) and other life-saving interventions may be necessary.
Prevention of MRI is crucial in reducing its incidence and severity. This involves aggressive risk factor management, such as controlling hypertension, diabetes, and dyslipidemia, as well as smoking cessation and stress reduction. Additionally, patients with a history of MI should adhere to their medication regimen, which may include beta blockers, ACE inhibitors or ARBs, statins, and aspirin.
In conclusion, myocardial injury with ST-segment elevation (MRI) is a life-threatening condition that requires prompt recognition and treatment. While the clinical presentation can vary depending on the severity of the injury, early diagnosis and management are crucial in reducing morbidity and mortality. Prevention through aggressive risk factor management and adherence to medication regimens is also essential in preventing MRI.
There are several possible causes of chest pain, including:
1. Coronary artery disease: The most common cause of chest pain is coronary artery disease, which occurs when the coronary arteries that supply blood to the heart become narrowed or blocked. This can lead to a heart attack if the blood flow to the heart muscle is severely reduced.
2. Heart attack: A heart attack occurs when the heart muscle becomes damaged or dies due to a lack of oxygen and nutrients. This can cause severe chest pain, as well as other symptoms such as shortness of breath, lightheadedness, and fatigue.
3. Acute coronary syndrome: This is a group of conditions that occur when the blood flow to the heart muscle is suddenly blocked or reduced, leading to chest pain or discomfort. In addition to heart attack, acute coronary syndrome can include unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI).
4. Pulmonary embolism: A pulmonary embolism occurs when a blood clot forms in the lungs and blocks the flow of blood to the heart, causing chest pain and shortness of breath.
5. Pneumonia: An infection of the lungs can cause chest pain, fever, and difficulty breathing.
6. Costochondritis: This is an inflammation of the cartilage that connects the ribs to the breastbone (sternum), which can cause chest pain and tenderness.
7. Tietze's syndrome: This is a condition that occurs when the cartilage and muscles in the chest are injured, leading to chest pain and swelling.
8. Heart failure: When the heart is unable to pump enough blood to meet the body's needs, it can cause chest pain, shortness of breath, and fatigue.
9. Pericarditis: An inflammation of the membrane that surrounds the heart (pericardium) can cause chest pain, fever, and difficulty breathing.
10. Precordial catch syndrome: This is a condition that occurs when the muscles and tendons between the ribs become inflamed, causing chest pain and tenderness.
These are just a few of the many possible causes of chest pain. If you are experiencing chest pain, it is important to seek medical attention right away to determine the cause and receive proper treatment.
Necrosis is a type of cell death that occurs when cells are exposed to excessive stress, injury, or inflammation, leading to damage to the cell membrane and the release of cellular contents into the surrounding tissue. This can lead to the formation of gangrene, which is the death of body tissue due to lack of blood supply.
There are several types of necrosis, including:
1. Coagulative necrosis: This type of necrosis occurs when there is a lack of blood supply to the tissues, leading to the formation of a firm, white plaque on the surface of the affected area.
2. Liquefactive necrosis: This type of necrosis occurs when there is an infection or inflammation that causes the death of cells and the formation of pus.
3. Caseous necrosis: This type of necrosis occurs when there is a chronic infection, such as tuberculosis, and the affected tissue becomes soft and cheese-like.
4. Fat necrosis: This type of necrosis occurs when there is trauma to fatty tissue, leading to the formation of firm, yellowish nodules.
5. Necrotizing fasciitis: This is a severe and life-threatening form of necrosis that affects the skin and underlying tissues, often as a result of bacterial infection.
The diagnosis of necrosis is typically made through a combination of physical examination, imaging studies such as X-rays or CT scans, and laboratory tests such as biopsy. Treatment depends on the underlying cause of the necrosis and may include antibiotics, surgical debridement, or amputation in severe cases.
Symptoms:
* Chest pain or discomfort
* Shortness of breath
* Coughing up blood
* Pain in the back or shoulders
* Dizziness or fainting
Diagnosis is typically made with imaging tests such as chest X-rays, CT scans, or MRI. Treatment may involve monitoring the aneurysm with regular imaging tests to check for growth, or surgery to repair or replace the affected section of the aorta.
This term is used in the medical field to identify a specific type of aneurysm and differentiate it from other types of aneurysms that occur in different locations.
1. Stroke: A stroke occurs when the blood supply to the brain is interrupted, either due to a blockage or a rupture of the blood vessels. This can lead to cell death and permanent brain damage.
2. Cerebral vasospasm: Vasospasm is a temporary constriction of the blood vessels in the brain, which can occur after a subarachnoid hemorrhage (bleeding in the space surrounding the brain).
3. Moyamoya disease: This is a rare condition caused by narrowing or blockage of the internal carotid artery and its branches. It can lead to recurrent transient ischemic attacks (TIs) or stroke.
4. Cerebral amyloid angiopathy: This is a condition where abnormal protein deposits accumulate in the blood vessels of the brain, leading to inflammation and bleeding.
5. Cavernous malformations: These are abnormal collections of blood vessels in the brain that can cause seizures, headaches, and other symptoms.
6. Carotid artery disease: Atherosclerosis (hardening) of the carotid arteries can lead to a stroke or TIAs.
7. Vertebrobasilar insufficiency: This is a condition where the blood flow to the brain is reduced due to narrowing or blockage of the vertebral and basilar arteries.
8. Temporal lobe dementia: This is a type of dementia that affects the temporal lobe of the brain, leading to memory loss and other cognitive symptoms.
9. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): This is a rare genetic disorder that affects the blood vessels in the brain, leading to recurrent stroke-like events.
10. Moyamoya disease: This is a rare condition caused by narrowing or blockage of the internal carotid artery and its branches, leading to decreased blood flow to the brain and increased risk of stroke.
It's important to note that this list is not exhaustive and there may be other causes of stroke and TIAs that are not included here. A proper diagnosis can only be made by a qualified medical professional after conducting a thorough examination and reviewing the individual's medical history.
Pathologic neovascularization can be seen in a variety of conditions, including cancer, diabetic retinopathy, and age-related macular degeneration. In cancer, for example, the formation of new blood vessels can help the tumor grow and spread to other parts of the body. In diabetic retinopathy, the growth of new blood vessels in the retina can cause vision loss and other complications.
There are several different types of pathologic neovascularization, including:
* Angiosarcoma: a type of cancer that arises from the cells lining blood vessels
* Hemangiomas: benign tumors that are composed of blood vessels
* Cavernous malformations: abnormal collections of blood vessels in the brain or other parts of the body
* Pyogenic granulomas: inflammatory lesions that can form in response to trauma or infection.
The diagnosis of pathologic neovascularization is typically made through a combination of physical examination, imaging studies (such as ultrasound, CT scans, or MRI), and biopsy. Treatment options vary depending on the underlying cause of the condition, but may include medications, surgery, or radiation therapy.
In summary, pathologic neovascularization is a process that occurs in response to injury or disease, and it can lead to serious complications. It is important for healthcare professionals to be aware of this condition and its various forms in order to provide appropriate diagnosis and treatment.
There are many different types of heart diseases, including:
1. Coronary artery disease: The buildup of plaque in the coronary arteries, which supply blood to the heart muscle, leading to chest pain or a heart attack.
2. Heart failure: When the heart is unable to pump enough blood to meet the body's needs, leading to fatigue, shortness of breath, and swelling in the legs.
3. Arrhythmias: Abnormal heart rhythms, such as atrial fibrillation or ventricular tachycardia, which can cause palpitations, dizziness, and shortness of breath.
4. Heart valve disease: Problems with the heart valves, which can lead to blood leaking back into the chambers or not being pumped effectively.
5. Cardiomyopathy: Disease of the heart muscle, which can lead to weakened heart function and heart failure.
6. Heart murmurs: Abnormal sounds heard during a heartbeat, which can be caused by defects in the heart valves or abnormal blood flow.
7. Congenital heart disease: Heart defects present at birth, such as holes in the heart or abnormal blood vessels.
8. Myocardial infarction (heart attack): Damage to the heart muscle due to a lack of oxygen, often caused by a blockage in a coronary artery.
9. Cardiac tamponade: Fluid accumulation around the heart, which can cause compression of the heart and lead to cardiac arrest.
10. Endocarditis: Infection of the inner lining of the heart, which can cause fever, fatigue, and heart valve damage.
Heart diseases can be diagnosed through various tests such as electrocardiogram (ECG), echocardiogram, stress test, and blood tests. Treatment options depend on the specific condition and may include lifestyle changes, medication, surgery, or a combination of these.
Example sentence: "The patient experienced a transient ischemic attack, which was caused by a temporary blockage in one of the blood vessels in their brain."
Synonyms: TIA, mini-stroke.
The symptoms of moyamoya disease typically begin in childhood or adolescence and can include:
* Recurring transient ischemic attacks (TIA, or "mini-strokes")
* Stroke or cerebral infarction
* Seizures
* Cognitive impairment or developmental delays
* Weakness or paralysis of the limbs
* Vision problems or blindness
The disease is caused by a combination of genetic and environmental factors, including:
* Genetic mutations that affect the formation and maintenance of blood vessels
* Environmental factors such as infections, trauma, or exposure to toxins
Moyamoya disease can be diagnosed through a variety of imaging tests, including:
* Computed tomography (CT) scans
* Magnetic resonance imaging (MRI)
* Magnetic resonance angiography (MRA)
* Positron emission tomography (PET) scans
There is no cure for moyamoya disease, but various treatments can be used to manage its symptoms and slow its progression. These may include:
* Medications to prevent or treat seizures, high blood pressure, or other complications
* Surgical procedures to improve blood flow to the brain, such as direct revascularization or bypass surgery
* Rehabilitation therapies to help regain lost function and mobility
Early diagnosis and treatment of moyamoya disease can help manage its symptoms and improve quality of life for affected individuals. However, because the disease is so rare and complex, it can be challenging to diagnose and treat effectively.
Brain neoplasms can arise from various types of cells in the brain, including glial cells (such as astrocytes and oligodendrocytes), neurons, and vascular tissues. The symptoms of brain neoplasms vary depending on their size, location, and type, but may include headaches, seizures, weakness or numbness in the limbs, and changes in personality or cognitive function.
There are several different types of brain neoplasms, including:
1. Meningiomas: These are benign tumors that arise from the meninges, the thin layers of tissue that cover the brain and spinal cord.
2. Gliomas: These are malignant tumors that arise from glial cells in the brain. The most common type of glioma is a glioblastoma, which is aggressive and hard to treat.
3. Pineal parenchymal tumors: These are rare tumors that arise in the pineal gland, a small endocrine gland in the brain.
4. Craniopharyngiomas: These are benign tumors that arise from the epithelial cells of the pituitary gland and the hypothalamus.
5. Medulloblastomas: These are malignant tumors that arise in the cerebellum, specifically in the medulla oblongata. They are most common in children.
6. Acoustic neurinomas: These are benign tumors that arise on the nerve that connects the inner ear to the brain.
7. Oligodendrogliomas: These are malignant tumors that arise from oligodendrocytes, the cells that produce the fatty substance called myelin that insulates nerve fibers.
8. Lymphomas: These are cancers of the immune system that can arise in the brain and spinal cord. The most common type of lymphoma in the CNS is primary central nervous system (CNS) lymphoma, which is usually a type of B-cell non-Hodgkin lymphoma.
9. Metastatic tumors: These are tumors that have spread to the brain from another part of the body. The most common types of metastatic tumors in the CNS are breast cancer, lung cancer, and melanoma.
These are just a few examples of the many types of brain and spinal cord tumors that can occur. Each type of tumor has its own unique characteristics, such as its location, size, growth rate, and biological behavior. These factors can help doctors determine the best course of treatment for each patient.
Some common types of brain diseases include:
1. Neurodegenerative diseases: These are progressive conditions that damage or kill brain cells over time, leading to memory loss, cognitive decline, and movement disorders. Examples include Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS).
2. Stroke: This occurs when blood flow to the brain is interrupted, leading to cell death and potential long-term disability.
3. Traumatic brain injury (TBI): This refers to any type of head injury that causes damage to the brain, such as concussions, contusions, or penetrating wounds.
4. Infections: Viral, bacterial, and fungal infections can all affect the brain, leading to a range of symptoms including fever, seizures, and meningitis.
5. Tumors: Brain tumors can be benign or malignant and can cause a variety of symptoms depending on their location and size.
6. Cerebrovascular diseases: These conditions affect the blood vessels of the brain, leading to conditions such as aneurysms, arteriovenous malformations (AVMs), and Moyamoya disease.
7. Neurodevelopmental disorders: These are conditions that affect the development of the brain and nervous system, such as autism spectrum disorder, ADHD, and intellectual disability.
8. Sleep disorders: Conditions such as insomnia, narcolepsy, and sleep apnea can all have a significant impact on brain function.
9. Psychiatric disorders: Mental health conditions such as depression, anxiety, and schizophrenia can affect the brain and its functioning.
10. Neurodegenerative with brain iron accumulation: Conditions such as Parkinson's disease, Alzheimer's disease, and Huntington's disease are characterized by the accumulation of abnormal proteins and other substances in the brain, leading to progressive loss of brain function over time.
It is important to note that this is not an exhaustive list and there may be other conditions or factors that can affect the brain and its functioning. Additionally, many of these conditions can have a significant impact on a person's quality of life, and it is important to seek medical attention if symptoms persist or worsen over time.
There are two types of heart arrest:
1. Asystole - This is when the heart stops functioning completely and there is no electrical activity in the heart.
2. Pulseless ventricular tachycardia or fibrillation - This is when the heart is still functioning but there is no pulse and the rhythm is abnormal.
Heart arrest can be diagnosed through various tests such as electrocardiogram (ECG), blood tests, and echocardiography. Treatment options for heart arrest include cardiopulmonary resuscitation (CPR), defibrillation, and medications to restore a normal heart rhythm.
In severe cases of heart arrest, the patient may require advanced life support measures such as mechanical ventilation and cardiac support devices. The prognosis for heart arrest is generally poor, especially if it is not treated promptly and effectively. However, with proper treatment and support, some patients can recover and regain normal heart function.
Symptoms of intracranial hypertension can include headache, nausea and vomiting, confusion, seizures, and loss of consciousness. Treatment options depend on the underlying cause, but may include medications to reduce pressure, draining excess CSF, or surgery to relieve obstruction.
Intracranial hypertension can be life-threatening if left untreated, as it can lead to permanent brain damage and even death. Therefore, prompt medical attention is essential for proper diagnosis and management of this condition.
The symptoms of an aortic aneurysm can vary depending on its size and location. Small aneurysms may not cause any symptoms at all, while larger ones may cause:
* Pain in the abdomen or back
* Pulsatile abdominal mass that can be felt through the skin
* Numbness or weakness in the legs
* Difficulty speaking or swallowing (if the aneurysm is pressing on the vocal cords)
* Sudden, severe pain if the aneurysm ruptures.
If you suspect that you or someone else may have an aortic aneurysm, it is important to seek medical attention right away. Aortic aneurysms can be diagnosed with imaging tests such as CT or MRI scans, and treated with surgery to repair or replace the affected section of the aorta.
In this article, we will discuss the causes and risk factors for aortic aneurysms, the symptoms and diagnosis of this condition, and the treatment options available. We will also cover the prognosis and outlook for patients with aortic aneurysms, as well as any lifestyle changes that may help reduce the risk of developing this condition.
CAUSES AND RISK FACTORS:
Aortic aneurysms are caused by weaknesses in the wall of the aorta, which can be due to genetic or acquired factors. Some of the known risk factors for developing an aortic aneurysm include:
* Age (the risk increases with age)
* Gender (men are more likely to develop an aortic aneurysm than women)
* Family history of aneurysms
* High blood pressure
* Atherosclerosis (the buildup of plaque in the arteries)
* Connective tissue disorders such as Marfan syndrome or Ehlers-Danlos syndrome
* Previous heart surgery or radiation therapy to the chest
SYMPTOMS:
In many cases, aortic aneurysms do not cause any symptoms in the early stages. However, as the aneurysm grows and puts pressure on nearby blood vessels or organs, patients may experience some of the following symptoms:
* Abdominal pain or discomfort
* Back pain
* Shortness of breath
* Dizziness or lightheadedness
* Fatigue
* Confusion or weakness
DIAGNOSIS:
Aortic aneurysms are typically diagnosed using imaging tests such as CT or MRI scans. These tests can provide detailed images of the aorta and help doctors identify any abnormalities or dilations. Other diagnostic tests may include echocardiography, ultrasound, or angiography.
TREATMENT:
The treatment for an aortic aneurysm will depend on the size and location of the aneurysm, as well as the patient's overall health. Some options may include:
* Monitoring: Small aneurysms that are not causing any symptoms may not require immediate treatment. Instead, doctors may recommend regular check-ups to monitor the aneurysm's size and progression.
* Surgery: If the aneurysm is large or growing rapidly, surgery may be necessary to repair or replace the affected section of the aorta. This may involve replacing the aneurysm with a synthetic tube or sewing a patch over the aneurysm to reinforce the aortic wall.
* Endovascular repair: In some cases, doctors may use a minimally invasive procedure called endovascular repair to treat the aneurysm. This involves inserting a small tube (called a stent) into the affected area through a small incision in the groin. The stent is then expanded to reinforce the aortic wall and prevent further growth of the aneurysm.
PROGNOSIS:
The prognosis for aortic aneurysms is generally good if they are detected and treated early. However, if left untreated, aortic aneurysms can lead to serious complications, such as:
* Aneurysm rupture: This is the most severe complication of aortic aneurysms and can be life-threatening. If the aneurysm ruptures, it can cause massive internal bleeding and potentially lead to death.
* Blood clots: Aortic aneurysms can increase the risk of blood clots forming in the affected area. These clots can break loose and travel to other parts of the body, causing further complications.
* Heart problems: Large aortic aneurysms can put pressure on the heart and surrounding vessels, leading to heart problems such as heart failure or coronary artery disease.
PREVENTION:
There is no guaranteed way to prevent aortic aneurysms, but there are several factors that may reduce the risk of developing one. These include:
* Family history: If you have a family history of aortic aneurysms, your doctor may recommend more frequent monitoring and check-ups to detect any potential problems early.
* High blood pressure: High blood pressure is a major risk factor for aortic aneurysms, so managing your blood pressure through lifestyle changes and medication can help reduce the risk.
* Smoking: Smoking is also a major risk factor for aortic aneurysms, so quitting smoking can help reduce the risk.
* Healthy diet: Eating a healthy diet that is low in salt and fat can help reduce the risk of developing high blood pressure and other conditions that may increase the risk of aortic aneurysms.
DIAGNOSIS:
Aortic aneurysms are typically diagnosed through a combination of physical examination, medical history, and imaging tests. These may include:
* Physical examination: Your doctor may check for any signs of an aneurysm by feeling your pulse and listening to your heart with a stethoscope. They may also check for any swelling or tenderness in your abdomen.
* Medical history: Your doctor will ask about your medical history, including any previous heart conditions or surgeries.
* Imaging tests: Imaging tests such as ultrasound, CT scan, or MRI can be used to confirm the diagnosis and measure the size of the aneurysm.
TREATMENT:
The treatment for aortic aneurysms depends on the size of the aneurysm and how quickly it is growing. For small aneurysms that are not growing, doctors may recommend regular monitoring with imaging tests to check the size of the aneurysm. For larger aneurysms that are growing rapidly, surgery may be necessary to repair or replace the aorta.
SURGICAL REPAIR:
There are several surgical options for repairing an aortic aneurysm, including:
* Open surgery: This is the traditional method of repairing an aortic aneurysm, where the surgeon makes an incision in the abdomen to access the aorta and repair the aneurysm.
* Endovascular repair: This is a minimally invasive procedure where the surgeon uses a catheter to insert a stent or graft into the aorta to repair the aneurysm.
POST-OPERATIVE CARE:
After surgery, you will be monitored in the intensive care unit for several days to ensure that there are no complications. You may have a drainage tube inserted into your chest to remove any fluid that accumulates during and after surgery. You will also have various monitors to check your heart rate, blood pressure, and oxygen levels.
RECOVERY:
The recovery time for aortic aneurysm repair can vary depending on the size of the aneurysm and the type of surgery performed. In general, patients who undergo endovascular repair have a faster recovery time than those who undergo open surgery. You may need to take medications to prevent blood clots and manage pain after surgery. You will also need to follow up with your doctor regularly to check on the healing of the aneurysm and the functioning of the heart.
LONG-TERM OUTLOOK:
The long-term outlook for patients who undergo aortic aneurysm repair is generally good, especially if the surgery is successful and there are no complications. However, patients with large aneurysms or those who have had complications during surgery may be at higher risk for long-term health problems. Some potential long-term complications include:
* Infection of the incision site or graft
* Inflammation of the aorta (aortitis)
* Blood clots forming in the graft or legs
* Narrowing or blockage of the aorta
* Heart problems, such as heart failure or arrhythmias.
It is important to follow up with your doctor regularly to monitor your condition and address any potential complications early on.
LIFESTYLE CHANGES:
After undergoing aortic aneurysm repair, you may need to make some lifestyle changes to help manage the condition and reduce the risk of complications. These may include:
* Avoiding heavy lifting or bending
* Taking regular exercise to improve cardiovascular health
* Eating a healthy diet that is low in salt and fat
* Quitting smoking, if you are a smoker
* Managing high blood pressure and other underlying medical conditions.
It is important to discuss any specific lifestyle changes with your doctor before making any significant changes to your daily routine. They can provide personalized guidance based on your individual needs and condition.
EMOTIONAL SUPPORT:
Undergoing aortic aneurysm repair can be a stressful and emotional experience, both for the patient and their loved ones. It is important to seek emotional support during this time to help cope with the challenges of the procedure and recovery. This may include:
* Talking to family and friends about your feelings and concerns
* Joining a support group for patients with aortic aneurysms or other cardiovascular conditions
* Seeking counseling or therapy to manage stress and anxiety
* Connecting with online resources and forums to learn more about the condition and share experiences with others.
Remember, it is important to prioritize your mental health and well-being during this time, as well as your physical health. Seeking emotional support can be an important part of the recovery process and can help you feel more supported and empowered throughout the journey.
There are several different types of brain injuries that can occur, including:
1. Concussions: A concussion is a type of mild traumatic brain injury that occurs when the brain is jolted or shaken, often due to a blow to the head.
2. Contusions: A contusion is a bruise on the brain that can occur when the brain is struck by an object, such as during a car accident.
3. Coup-contrecoup injuries: This type of injury occurs when the brain is injured as a result of the force of the body striking another object, such as during a fall.
4. Penetrating injuries: A penetrating injury occurs when an object pierces the brain, such as during a gunshot wound or stab injury.
5. Blast injuries: This type of injury occurs when the brain is exposed to a sudden and explosive force, such as during a bombing.
The symptoms of brain injuries can vary depending on the severity of the injury and the location of the damage in the brain. Some common symptoms include:
* Headaches
* Dizziness or loss of balance
* Confusion or disorientation
* Memory loss or difficulty with concentration
* Slurred speech or difficulty with communication
* Vision problems, such as blurred vision or double vision
* Sleep disturbances
* Mood changes, such as irritability or depression
* Personality changes
* Difficulty with coordination and balance
In some cases, brain injuries can be treated with medication, physical therapy, and other forms of rehabilitation. However, in more severe cases, the damage may be permanent and long-lasting. It is important to seek medical attention immediately if symptoms persist or worsen over time.
The symptoms of microvascular angina are similar to those of stable angina, including chest pain or discomfort, shortness of breath, and fatigue. However, microvascular angina episodes can be more frequent and unpredictable than stable angina, and may occur at rest or with minimal exertion.
The diagnosis of microvascular angina is based on a combination of clinical symptoms, physical examination findings, and diagnostic tests such as electrocardiography (ECG), echocardiography, and coronary angiography. Treatment for microvascular angina typically involves medications to relax the blood vessels and improve blood flow to the heart, as well as lifestyle changes such as regular exercise and a healthy diet. In severe cases, surgical intervention may be necessary.
Microvascular angina is considered a syndrome rather than a disease, and it is believed to be caused by a combination of genetic and environmental factors, including smoking, high blood pressure, and high cholesterol levels. It is more common in people who are middle-aged or older, and affects men and women equally.
Overall, microvascular angina is a serious condition that can have a significant impact on quality of life, and it is important for individuals who experience symptoms to seek medical attention to receive an accurate diagnosis and appropriate treatment. With proper management, many people with microvascular angina are able to lead active and fulfilling lives.
1. Infection: Bacterial or viral infections can develop after surgery, potentially leading to sepsis or organ failure.
2. Adhesions: Scar tissue can form during the healing process, which can cause bowel obstruction, chronic pain, or other complications.
3. Wound complications: Incisional hernias, wound dehiscence (separation of the wound edges), and wound infections can occur.
4. Respiratory problems: Pneumonia, respiratory failure, and atelectasis (collapsed lung) can develop after surgery, particularly in older adults or those with pre-existing respiratory conditions.
5. Cardiovascular complications: Myocardial infarction (heart attack), cardiac arrhythmias, and cardiac failure can occur after surgery, especially in high-risk patients.
6. Renal (kidney) problems: Acute kidney injury or chronic kidney disease can develop postoperatively, particularly in patients with pre-existing renal impairment.
7. Neurological complications: Stroke, seizures, and neuropraxia (nerve damage) can occur after surgery, especially in patients with pre-existing neurological conditions.
8. Pulmonary embolism: Blood clots can form in the legs or lungs after surgery, potentially causing pulmonary embolism.
9. Anesthesia-related complications: Respiratory and cardiac complications can occur during anesthesia, including respiratory and cardiac arrest.
10. delayed healing: Wound healing may be delayed or impaired after surgery, particularly in patients with pre-existing medical conditions.
It is important for patients to be aware of these potential complications and to discuss any concerns with their surgeon and healthcare team before undergoing surgery.
There are several causes of hypotension, including:
1. Dehydration: Loss of fluids and electrolytes can cause a drop in blood pressure.
2. Blood loss: Losing too much blood can lead to hypotension.
3. Medications: Certain medications, such as diuretics and beta-blockers, can lower blood pressure.
4. Heart conditions: Heart failure, cardiac tamponade, and arrhythmias can all cause hypotension.
5. Endocrine disorders: Hypothyroidism (underactive thyroid) and adrenal insufficiency can cause low blood pressure.
6. Vasodilation: A condition where the blood vessels are dilated, leading to low blood pressure.
7. Sepsis: Severe infection can cause hypotension.
Symptoms of hypotension can include:
1. Dizziness and lightheadedness
2. Fainting or passing out
3. Weakness and fatigue
4. Confusion and disorientation
5. Pale, cool, or clammy skin
6. Fast or weak pulse
7. Shortness of breath
8. Nausea and vomiting
If you suspect that you or someone else is experiencing hypotension, it is important to seek medical attention immediately. Treatment will depend on the underlying cause of the condition, but may include fluids, electrolytes, and medication to raise blood pressure. In severe cases, hospitalization may be necessary.
Dissecting aneurysms are often caused by trauma, such as a car accident or fall, but they can also be caused by other factors such as atherosclerosis (hardening of the arteries) or inherited conditions. They can occur in any blood vessel, but are most common in the aorta, which is the main artery that carries oxygenated blood from the heart to the rest of the body.
Symptoms of dissecting aneurysms can include sudden and severe pain, numbness or weakness, and difficulty speaking or understanding speech. If left untreated, a dissecting aneurysm can lead to serious complications such as stroke, heart attack, or death.
Treatment for dissecting aneurysms typically involves surgery to repair the damaged blood vessel. In some cases, endovascular procedures such as stenting or coiling may be used to treat the aneurysm. The goal of treatment is to prevent further bleeding and damage to the blood vessel, and to restore normal blood flow to the affected area.
Preventive measures for dissecting aneurysms are not always possible, but maintaining a healthy lifestyle, avoiding trauma, and managing underlying conditions such as hypertension or atherosclerosis can help reduce the risk of developing an aneurysm. Early detection and treatment are key to preventing serious complications and improving outcomes for patients with dissecting aneurysms.
Liver neoplasms, also known as liver tumors or hepatic tumors, are abnormal growths of tissue in the liver. These growths can be benign (non-cancerous) or malignant (cancerous). Malignant liver tumors can be primary, meaning they originate in the liver, or metastatic, meaning they spread to the liver from another part of the body.
There are several types of liver neoplasms, including:
1. Hepatocellular carcinoma (HCC): This is the most common type of primary liver cancer and arises from the main cells of the liver (hepatocytes). HCC is often associated with cirrhosis and can be caused by viral hepatitis or alcohol abuse.
2. Cholangiocarcinoma: This type of cancer arises from the cells lining the bile ducts within the liver (cholangiocytes). Cholangiocarcinoma is rare and often diagnosed at an advanced stage.
3. Hemangiosarcoma: This is a rare type of cancer that originates in the blood vessels of the liver. It is most commonly seen in dogs but can also occur in humans.
4. Fibromas: These are benign tumors that arise from the connective tissue of the liver (fibrocytes). Fibromas are usually small and do not spread to other parts of the body.
5. Adenomas: These are benign tumors that arise from the glandular cells of the liver (hepatocytes). Adenomas are usually small and do not spread to other parts of the body.
The symptoms of liver neoplasms vary depending on their size, location, and whether they are benign or malignant. Common symptoms include abdominal pain, fatigue, weight loss, and jaundice (yellowing of the skin and eyes). Diagnosis is typically made through a combination of imaging tests such as CT scans, MRI scans, and ultrasound, and a biopsy to confirm the presence of cancer cells.
Treatment options for liver neoplasms depend on the type, size, location, and stage of the tumor, as well as the patient's overall health. Surgery may be an option for some patients with small, localized tumors, while others may require chemotherapy or radiation therapy to shrink the tumor before surgery can be performed. In some cases, liver transplantation may be necessary.
Prognosis for liver neoplasms varies depending on the type and stage of the cancer. In general, early detection and treatment improve the prognosis, while advanced-stage disease is associated with a poorer prognosis.
The "no-reflow" phenomenon is defined as the absence of hyperemia (increased blood flow) in the myocardium after successful reperfusion therapy, which includes primary percutaneous coronary intervention (PCI) or thrombolysis. It is characterized by a decrease in the size of the infarct area, but not complete resolution of the infarction.
The no-reflow phenomenon can be diagnosed using various techniques such as echocardiography, cardiac magnetic resonance imaging (MRI), and single-photon emission computed tomography (SPECT) myocardial perfusion imaging. Treatment for the no-reflow phenomenon is aimed at addressing the underlying cause, such as managing blood pressure, controlling blood sugar levels, and administering medications to reduce inflammation and improve coronary blood flow.
In summary, the no-reflow phenomenon is a complex condition that can occur after reperfusion therapy, characterized by reduced or absent blood flow to certain areas of the heart muscle despite adequate perfusion pressure. Prompt diagnosis and appropriate treatment are essential to prevent further damage and improve outcomes in patients with this condition.
Some examples of pathologic constrictions include:
1. Stenosis: A narrowing or constriction of a blood vessel or other tubular structure, often caused by the buildup of plaque or scar tissue.
2. Asthma: A condition characterized by inflammation and constriction of the airways, which can make breathing difficult.
3. Esophageal stricture: A narrowing of the esophagus that can cause difficulty swallowing.
4. Gastric ring constriction: A narrowing of the stomach caused by a band of tissue that forms in the upper part of the stomach.
5. Anal fissure: A tear in the lining of the anus that can cause pain and difficulty passing stools.
Pathologic constrictions can be caused by a variety of factors, including inflammation, infection, injury, or genetic disorders. They can be diagnosed through imaging tests such as X-rays, CT scans, or endoscopies, and may require surgical treatment to relieve symptoms and improve function.
There are two types of hypertension:
1. Primary Hypertension: This type of hypertension has no identifiable cause and is also known as essential hypertension. It accounts for about 90% of all cases of hypertension.
2. Secondary Hypertension: This type of hypertension is caused by an underlying medical condition or medication. It accounts for about 10% of all cases of hypertension.
Some common causes of secondary hypertension include:
* Kidney disease
* Adrenal gland disorders
* Hormonal imbalances
* Certain medications
* Sleep apnea
* Cocaine use
There are also several risk factors for hypertension, including:
* Age (the risk increases with age)
* Family history of hypertension
* Obesity
* Lack of exercise
* High sodium intake
* Low potassium intake
* Stress
Hypertension is often asymptomatic, and it can cause damage to the blood vessels and organs over time. Some potential complications of hypertension include:
* Heart disease (e.g., heart attacks, heart failure)
* Stroke
* Kidney disease (e.g., chronic kidney disease, end-stage renal disease)
* Vision loss (e.g., retinopathy)
* Peripheral artery disease
Hypertension is typically diagnosed through blood pressure readings taken over a period of time. Treatment for hypertension may include lifestyle changes (e.g., diet, exercise, stress management), medications, or a combination of both. The goal of treatment is to reduce the risk of complications and improve quality of life.
Perfusion
Machine perfusion
Perfusion MRI
Limb perfusion
Retrograde perfusion
Perfusion scanning
Perfusion (journal)
Cerebral perfusion pressure
Isolated lung perfusion
Ventilation perfusion mismatch
Push-pull perfusion
Ventilation-perfusion coupling
Percutaneous hepatic perfusion
Myocardial perfusion imaging
Isolated hepatic perfusion
Acid perfusion test
Coronary perfusion pressure
Minusheet perfusion culture system
Continuous hyperthermic peritoneal perfusion
Twin reversed arterial perfusion
Isolated organ perfusion technique
Selective aortic arch perfusion
Cardiac magnetic resonance imaging perfusion
American Academy of Cardiovascular Perfusion
Purmorphamine
Post-cardiac arrest syndrome
Bubble oxygenator
Vasodilatory shock
Intraoperative blood salvage
Cardiopulmonary bypass
Renal perfusion scintiscan: MedlinePlus Medical Encyclopedia
Myocardial Perfusion Imaging | Service Listing | Ih
Advanced Catheter Therapies Receives FDA Approval for Occlusion Perfusion Catheter (VIDEO)
Cerebral perfusion and cognitive decline in type 2 diabetes v1.0.1
Long-term lung perfusion changes related to COVID-19: a dual energy computed tomography study
Perfusion - WSCUC
Procedure Guideline for Brain Perfusion SPECT Using Technetium-99m Radiopharmaceuticals | Journal of Nuclear Medicine
Jostra HL20 Perfusion System - Roller Pump Medical Battery Set
Can we justify not doing liver perfusion imaging in 2013 ? | CREATIS
Intravascular Perfusion of Carbon Black Ink Allows Reliable Visualization of Cerebral Vessels | Protocol (Translated to...
Assessment of myocardial perfusion and contractile function by inotropic stress Tc-99m sestamibi SPECT imaging and...
Spin-Echo Echo-Planar Perfusion MR Imaging in the Differential Diagnosis of Solitary Enhancing Brain Lesions: Distinguishing...
Choriocapillaris perfusion assessed using swept source optical coherence tomographic angiography and the severity of diabetic...
CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke.
Baba Farid University Of Health Sciences
B.Sc Perfusion Technology I Year Feb 2018 Exam Time Table
Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke | Neurology
Cerebral perfusion in cerebral malaria - MORU Tropical Health Network
COMPARAISON DU RETENTISSEMENT SUR LA PERFUSION TISSULAIRE DU BRULE DE DEUX AGENTS NARCOTIQUES LORS DE L'ANESTHESIE GENERALE...
Mechanical modeling and numerical methods for poromechanics : Application to myocardium perfusion - TEL - Thèses en ligne
Interstitial lung disease induced by antibiotics. MDCT with perfusion, MRI with DWI and MDCT guided lung biopsy
New Insight into Microvascular Perfusion by Analyzing Pipe Flow in a Cylindrical Elastic Shell
YR1: Clinical Applications of MR Perfusion to Characterize Histologic Heterogeneity in the Post-Treatment Glioma Bed:...
Performance of laser-derived imaging for assessing digital perfusion in clinical trials of systemic sclerosis-related digital...
Automatic Quantification of Liver-heart Cross Talk for Quality Assessment in SPECT Myocardial Perfusion Imaging | Center for...
Cardiac MRI, Technical Aspects Primer: Overview, Imaging Planes, Electrocardiographic Gating
Perfusion - EU Original
Brain Perfusion Scan
Perfusion | Sage India
Pulmonary embolism: Role of ventilation-perfusion scintigraphy<...
Perfusion computed tomography findings of autoimmune pancreatitis. | Pancreas;40(8): 1295-301, 2011 Nov. | MEDLINE
Myocardial9
- Myocardial perfusion imaging (MPI) is a nuclear medicine procedure that uses special radiotracers (or imaging agents) to trace how fast they are taken up by the heart muscle. (interiorhealth.ca)
- Objective To assess whether inotropic stress myocardial perfusion imaging, echocardiography, or a combination of the two could enhance the detection of multivessel disease, over and above clinical and exercise electrocardiographic data. (bmj.com)
- Conclusions The assessment of both myocardial perfusion and contractile function by simultaneous inotropic stress MIBI imaging and echocardiography optimises the non-invasive detection of multivessel disease. (bmj.com)
- 1 The detection of flow heterogeneity forms the conceptual basis for myocardial perfusion imaging, and systolic wall thickening abnormality is readily detected by echocardiography. (bmj.com)
- As these manifestations occur before the onset of symptoms and electrocardiographic changes, it is not surprising that many studies have shown that exercise and pharmacological stress testing, in conjunction with myocardial perfusion imaging or echocardiography, is superior to electrocardiography for detecting coronary artery disease. (bmj.com)
- 6-8 Whether the combination of stress myocardial perfusion imaging and echocardiography can enhance the detection of multivessel disease in conjunction with clinical and exercise electrocardiographic variables has not previously been investigated. (bmj.com)
- Inotropic stress testing (using dobutamine or arbutamine) is a safe, accurate, and increasingly used technique for evaluating coronary artery disease, 9-14 and whether it is used in conjunction with myocardial perfusion imaging or echocardiography, its diagnostic efficacy is similar to dynamic exercise. (bmj.com)
- Other applications, such as evaluation of myocardial perfusion and of valvular and ventricular function, are very accurately performed with MRI, but competing modalities, such as single-photon emission computed tomography (SPECT) scanning and echocardiography, are more commonly used in clinical practice. (medscape.com)
- It contains seventy teaching cases, presented with relevant clinical information such as case history, imaging/study data, and myocardial perfusion SPECT images. (bvsalud.org)
Tomography6
- Although the findings of acute new coronavirus disease (COVID-19) infection on dual-energy computed tomography (DECT) have recently been defined, the long-term changes in lung perfusion associated with COVID-19 pneumonia have not yet been clarified. (nih.gov)
- Dual-energy computed tomography can be used to reveal long-term parenchymal and perfusion changes. (nih.gov)
- Aims To investigate the relationship between choriocapillaris (CC) blood perfusion and the severity of diabetic retinopathy (DR) using swept-source optical coherence tomography angiography (SS-OCTA). (bmj.com)
- Perfusion computed tomography findings of autoimmune pancreatitis. (bvsalud.org)
- Perfusion computed tomography was performed in 11 patients with AIP and 12 control subjects. (bvsalud.org)
- Nine patients with AIP were reexamined by perfusion computed tomography after corticosteroid administration . (bvsalud.org)
Myocardium1
- It is motivated by the introduction into existing cardiac models of the coronary network that perfuses the myocardium, to better describe coronary vascular diseases.Drawing our inspiration from existing works, we propose a perfused heart model, and a 0D reduction allowing the cost-effective reproduction of a realistic cardiac cycle with perfusion mass and pressure. (hal.science)
Cardiac4
- Perfusion is an ISI-ranked, peer-reviewed scholarly journal, which provides current information on all aspects of perfusion, oxygenation and biocompatibility and their use in modern cardiac surgery. (sagepub.com)
- Perfusion is an ISI-ranked, peer-reviewed scholarly journal, which provides current information on all aspects of perfusion, oxygenation and biocompatibility and other extracorporeal technologies as used in cardiac surgery and extracorporeal membrane oxygenation (ECMO). (sagepub.com)
- Perfusion imaging allows detection of ischemia and measurement of blood flow quantifies cardiac shunts and valve disorders. (medscape.com)
- At 20 days post-exposure, the animals underwent cardiac perfusion to fix their cochleae. (cdc.gov)
Cerebral1
- CT perfusion cerebral blood volume does not always predict infarct core in acute ischemic stroke. (snacc.org)
Ventricular1
- Conclusion: Microvascular perfusion maintains a considerable constancy of hemodynamics in different tissues, when ventricular contraction changes perfusion pressure to meet metabolic demands appropriately. (scirp.org)
Echocardiography1
- The presence of perfusion defects with MIBI imaging or of wall thickening abnormality with echocardiography in at least two coronary artery territories at peak stress was taken as diagnostic of multivessel disease. (bmj.com)
Imaging4
- Percentage recovery analysis of time-intensity curves from gradient-echo echo-planar (GE-EPI) dynamic susceptibility contrast perfusion-weighted imaging (PWI) 1 has been proposed to distinguish these tumor types by assessing increased capillary permeability in brain metastasis, but to our knowledge, no published report yet documents the accuracy of this method. (ajnr.org)
- Article abstract Diffusion-weighted imaging (DWI) and perfusion imaging (PI) are two new magnetic resonance technologies that are becoming increasingly available for evaluation of acute ischemic stroke patients. (neurology.org)
- 6 During this "decade of the brain," two new MRI techniques that have the potential to improve acute stroke diagnosis and management during the critical initial hours after onset-diffusion-weighted imaging (DWI) and perfusion imaging (PI)-became available ( figure 1 ). (neurology.org)
- Laser Doppler flowmetry (LDF), Laser Doppler Imaging (LDI) and Laser Speckle Contrast Imaging (LSCI) can non-invasively quantify digital perfusion and may be useful outcome measures for SSc-RP and/or SSc-DU clinical trials. (bath.ac.uk)
Ischemia1
- Acute compartment syndrome occurs when the tissue pressure within a closed muscle compartment exceeds the perfusion pressure and results in muscle and nerve ischemia. (medscape.com)
Heterogeneity1
- YR1: Clinical Applications of MR Perfusion to Characterize Histologic Heterogeneity in the Post-Treatment Glioma Bed: Developing Safe and Accurate. (elsevier.com)
Findings1
- We aimed to examine the longterm course of lung perfusion in COVID-19 pneumonia cases using DECT and to compare changes in lung perfusion to clinical and laboratory findings. (nih.gov)
Clinical1
- Full-field perfusion of the digits (with/without provocation testing) is a promising clinical trial outcome measure for trials of SSc-related digital vasculopathy. (bath.ac.uk)
Deficit3
Assessment1
- Conclusion Quantitative FD density, number and size assessed by using SS-OCTA were independently correlated with the severity of DR. The assessment of the CC perfusion metrics in the macula may be a sensitive biomarker of DR changes. (bmj.com)
Characteristics1
- Aim: The aim of this research is to analyze the characteristics of microvascular perfusion by conducting pipe flow in a circular elastic tube. (scirp.org)
Appropriately1
- The journal is at the forefront of international research and development and presents an appropriately multidisciplinary approach to perfusion science. (sagepub.com)
Methods1
- Methods: A model was established with circular elastic tube to mimic microvascular perfusion. (scirp.org)
Nuclear1
- A renal perfusion scintiscan is a nuclear medicine test. (medlineplus.gov)
Diagnostic1
- The Occlusion Perfusion Catheter solves the problem of vascular re-stenosis by using a multi-lumen balloon catheter with two side balloons to create a temporary occlusion so that diagnostic or pharmacological agents can be delivered to a specific region of the vasculature. (medgadget.com)
Pressure2
- Background: Microvascular perfusion, a kind of regional perfusion, plays important roles in delivering oxygen and nutrients, and regulating blood pressure and responses to inflammation. (scirp.org)
- This 1976 transmission electron microscopic (TEM) image depicted a cross-sectional view of a normal, uninfected mouse brain capillary that has been perfusion-fixed at normal blood pressure. (cdc.gov)
Search1
- Results of search for 'su:{Perfusion. (who.int)
Presence1
- DWI provides information about the location of acute focal ischemic brain injury at early time points and PI can document the presence of disturbances in microcirculatory perfusion. (neurology.org)
Original1
- We guarantee the best price and 100% compatibility with the original Jostra HL20 Perfusion System - Roller Pump batteries. (batterysharks.com)
Study1
- Fifteen randomized and 14 non-randomized trials (total of 689 SSc patients with mean 23.8/study) have evaluated a broad range of oral, intravenous and topical interventions for SSc-RP (n = 11), digital perfusion alone (n = 15) and SSc-DU (n = 3). (bath.ac.uk)
Process1
- Selected papers presented at each annual meeting are published in Perfusion following the peer-review process. (sagepub.com)
Patients2
- Nous avons r alis une tude prospective pour valuer la perfusion tissulaire par m thode non invasive, associant l'enregistrement continu du d bit aortique par voie endo -oesophagienne et de la capnographie chez 27 patients b n ficiant d'une greffe dermo- pidermique sous anesth sie g n rale. (medbc.com)
- Pancreatic volumetric perfusion was attenuated in AIP patients . (bvsalud.org)
Medical3
- Jostra HL20 Perfusion System - Roller Pump Medical Battery Set has been added to cart! (batterysharks.com)
- The brand new Jostra HL20 Perfusion System - Roller Pump medical battery set is factory fresh and of a very high quality. (batterysharks.com)
- If you need assistance with purchasing Jostra HL20 Perfusion System - Roller Pump medical batteries, please contact our customer service department at (800) 657-1303 or e-mail us . (batterysharks.com)
Treatment1
- The perfusion was improved after the steroid treatment . (bvsalud.org)